In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
All 198 Salmonella isolates (58.6% of isolates were resistant to tetracycline), 92 Vibrio isolates (4.4% of isolates were resistant to tetracycline), and 200 of 201 Aeromonas isolates (39.3% of isolates were resistant to tetracycline; 1 A. caviae isolate had a tigecycline MIC of 4 mug/ml) in our study were susceptible to tigecycline, by U. S. Food and Drug Administration criteria for Enterobacteriaceae.
Liu
Chia-Ying
CY
Section of Infectious Diseases, Department of Internal Medicine, Far-Eastern Memorial Hospital, Taiwan.
Huang
Yu-Tsung
YT
Liao
Chun-Hsing
CH
Hsueh
Po-Ren
PR
D000333:Aeromonas / Q000187:drug effects* / Q000302:isolation & purification; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology; D012475:Salmonella / Q000187:drug effects* / Q000302:isolation & purification; D012480:Salmonella Infections / Q000188:drug therapy / Q000382:microbiology; D013624:Taiwan; D013753:Tetracycline Resistance; D000078304:Tigecycline; D014733:Vibrio / Q000187:drug effects* / Q000302:isolation & purification; D014735:Vibrio Infections / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline